Navigation Links
Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign
Date:5/4/2011

INDIANAPOLIS, May 5, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and The Mind Trust, an Indianapolis-based nonprofit that supports bold, new education reform, today announced the launch of The Mind Trust's Grow What Works campaign. Grow What Works seeks to raise and invest $18 million in the highest-impact education organizations working in Indianapolis, enabling them to serve more students and accelerate education reform. Lilly is investing $2.5 million in the Grow What Works campaign, the company's largest ever education-focused grant.

Since its founding in 2006, The Mind Trust has been strategically building a network of the nation's best education reform organizations in Indianapolis. Together, these organizations, led by visionary education entrepreneurs, are already working to transform public education in the city. Lilly believes that aggressively growing these organizations, as well as investing in new, innovative ideas and models through The Mind Trust's Grow What Works campaign represents the most promising strategy for the private sector to invest in change.

"We believe that providing access to an excellent education for all of our children is the key to our city's future," said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer. "Lilly has been impressed with the work of The Mind Trust.  It has amassed an impressive record of making strategic investments and has become a recognized model for leading education reform. We're honored to invest in the Grow What Works campaign, and we encourage other organizations to do the same. The Mind Trust is uniquely positioned to be an effective catalyst for education reform in Indianapolis."

The Grow What Works campaign will elevate Indianapolis in the national education reform conversation. "The islands of excellence that now exist in school districts have to become t
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... -- FireflySci Inc., the newest member of the cuvette manufacturing world, opened their doors to ... industry on its head by offering scientists amazing support for their spectroscopy needs.  ... ... ... ...
(Date:5/4/2015)... JUPITER, Fla. , May 4, 2015 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... and other proteins for the bioenergy, bio-based chemical, ... it will report its financial results for quarter ... Thursday, May 14, 2015 and will host a ...
(Date:5/4/2015)... -- Intarcia Therapeutics, Inc. today announced ... the newly created role of Chief Operating Officer ... with world-class experience – most recently at Takeda ... industry leaders such as Pfizer and Bristol Myers ... therapeutic areas, including: cardiovascular, metabolic, oncology, neuroscience, gastrointestinal, ...
Breaking Medicine Technology:New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
... Novartis Pharmaceuticals Corporation ("Novartis") announced today that ... Drugs Advisory Committee (ODAC) recommended approval of Afinitor® ... advanced neuroendocrine tumors (NET) of pancreatic origin. ... data from the everolimus RADIANT (RAD001 In Advanced ...
... 12, 2011 MSA (NYSE: MSA ), the ... that protect people,s health and safety, announced today that it ... via the Internet on Thursday, April 28, 2011 at 10:00 ... Investors and interested parties will have the opportunity ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10MSA Schedules First Quarter Earnings Webcast 2
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... NC (PRWEB) May 04, 2015 CCL, ... to offer this unique program to other leadership development ... valuable ties between CCL and successful practitioners, expanding our ... around the globe,” said John R. Ryan, CCL President ... joins the CCL Partner Network , it will ...
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... Pa. (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen ... the hopes that it would remind others in similar situations ... A Recovery from Chronic Pain and Discovery of New Energy” ... with a new audience via a renewed press campaign. , ... with debilitating pain ,” Hawthorn-Deppen says. “As an adolescent ...
(Date:5/4/2015)... 04, 2015 Fast on the heels ... Trace Amounts, and Allison Folmar, JD, join over 150 ... internationally. , On Sunday, May 24, the conference presents ... possible?" Are you interested in Ryan Hinds' recovery story? ... our war against autism was written by Marcia ...
Breaking Medicine News(10 mins):Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4
... bill granting temporary relief from looming cuts to Medicare ... with millions of patientscontinues to face significant threats to ... "This is good news, and we are ... delay reimbursement cuts to medical imaging," said Michael M. ...
... of Urology opened its 25th Anniversary Congress. During the ... the outstanding work they did for the urological community. ... The EAU Willy Gregoir Medal is the highest ... It was awarded to Prof.,Frans Debruyne (NL) for his ...
... ... to offer strategies for talent development and explore the decision science of workforce analytics, ... Irving, Texas ... solutions, will bring sought-after Human Resources industry speakers Marc Effron, president at The Talent ...
... of life, researchers say , FRIDAY, April 16 (HealthDay News) ... significant improvements in their ability to move their limbs, and ... , The study, by the U.S. Department of Veterans Affairs ... Journal of Medicine , offers the strongest evidence yet that ...
... clock, TeleCare, a home monitoring device, gives the chronically ill ... Researchers from Case Western Reserve University and Cleveland State University ... complex health issues healthy and out of the hospital. ... one-year pilot grant to investigators Elizabeth Madigan from the Frances ...
... ... Wide Format Digital Printing and ID Badge divisions. , ... Memphis, TN (PRWEB) April 16, 2010 -- Memphis-based ... The company’s two distinct product divisions, Wide Format Digital Printing and ID Badge Systems, ...
Cached Medicine News:Health News:SNM applauds temporary freeze on Medicare cuts 2Health News:Talent Management Guru Marc Effron and Workforce Analytics Expert Al Adamsen to Deliver Keynote Speeches at Aquire's Annual User Conference 2Health News:Talent Management Guru Marc Effron and Workforce Analytics Expert Al Adamsen to Deliver Keynote Speeches at Aquire's Annual User Conference 3Health News:Robot-Aided Therapy Can Help Patients Years After Stroke 2Health News:CWRU study examines effectiveness of telemonitoring vital signs 2Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 2Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: